Pemgarda, a monoclonal antibody for unknown version of covid receives and EUA

SASHA LATYPOVA APR 03, 2024 READ

I can’t begin to describe how stupid this is, and any honest doctor can confirm this (if you find and honest doctor, ask them). Just a few years ago, if I told to my colleagues that a “prophylactic” monoclonal antibody will be greenlighted by the FDA based on a theoretical levels of an unvalidated theoretical surrogate marker of immune response (antibody titers), I would have been laughed out of the room. But those days are sadly over.